Form 4: Medtronic CEO Exercises Stock Options and Sells Shares

Medtronic's CEO, Geoffrey Martha, exercised stock options and sold a portion of the acquired shares on January 27, 2025.

Summary

• Geoffrey Martha, the Chairman and CEO of Medtronic, executed a transaction involving Medtronic ordinary shares on January 27, 2025.
• Mr. Martha exercised stock options to acquire 34,741 ordinary shares at a price of $74.84 per share.
• Following the exercise of options, Mr. Martha sold 30,184 ordinary shares at a price of $92.46 per share.
• After these transactions, Mr. Martha directly owns 186,770 ordinary shares of Medtronic, which includes 887 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself.

Industry Context

This is a routine filing related to executive stock option exercises and sales, which is common in publicly traded companies. It does not indicate any specific trend or event in the medical device industry.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice across publicly traded companies, including those in the medical device industry.
• Companies like Abbott, Boston Scientific, and Stryker also have similar filings related to their executives' stock transactions.
• The reported prices are within the expected range for Medtronic's stock performance.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine executive stock transaction.

Key Dates

Keywords

Medtronic, stock options, share sale, insider trading, executive compensation, Geoffrey Martha, MDT